We are live on ! Find out more
MJP

Michael J. Puzo Portfolio holdings

AUM $343M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$360M
AUM Growth
-$485K
Cap. Flow
-$6.21M
Cap. Flow %
-1.72%
Top 10 Hldgs %
41.32%
Holding
75
New
–
Increased
13
Reduced
49
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.15M
2
CARR icon
Carrier Global
CARR
+$2.12M
3
BALL icon
Ball Corp
BALL
+$1.89M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$1.75M
5
UNH icon
UnitedHealth
UNH
+$469K

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$3.9M
2
NVS icon
Novartis
NVS
+$2.17M
3
NVDA icon
NVIDIA
NVDA
+$1.34M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$842K
5
AMD icon
Advanced Micro Devices
AMD
+$675K

Sector Composition

Rank Sector Weight
1 Technology 29.59%
2 Healthcare 20.43%
3 Industrials 12.86%
4 Consumer Discretionary 9.82%
5 Financials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$651B
$4.49M 1.25%
39,029
-600
-2% -$69.9K
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$121B
$4.48M 1.24%
9,566
+4,953
+107% +$2.15M
CARR icon
28
Carrier Global
CARR
$57.2B
$4.21M 1.17%
66,683
+34,540
+107% +$2.12M
MDT icon
29
Medtronic
MDT
$107B
$3.62M 1.01%
46,024
-4,899
-10% -$402K
BALL icon
30
Ball Corp
BALL
$17B
$3.49M 0.97%
58,085
+28,217
+94% +$1.89M
PEP icon
31
PepsiCo
PEP
$186B
$3.17M 0.88%
19,219
-420
-2% -$72.5K
MKC icon
32
McCormick & Company Non-Voting
MKC
$13.4B
$2.86M 0.79%
40,372
+24,022
+147% +$1.75M
MRK icon
33
Merck
MRK
$324B
$2.58M 0.71%
20,805
-505
-2% -$65K
ABBV icon
34
AbbVie
ABBV
$458B
$1.85M 0.51%
10,764
-305
-3% -$50.5K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.57M 0.44%
3,870
-1,405
-27% -$574K
APTV icon
36
Aptiv
APTV
$12B
$1.41M 0.39%
20,090
+470
+2% +$36.1K
NVS icon
37
Novartis
NVS
$295B
$1.4M 0.39%
13,145
-21,665
-62% -$2.17M
EMR icon
38
Emerson Electric
EMR
$82.9B
$1.07M 0.3%
9,727
-390
-4% -$43.1K
WMT icon
39
Walmart Inc
WMT
$871B
$982K 0.27%
14,499
-1,398
-9% -$88K
CAT icon
40
Caterpillar
CAT
$409B
$903K 0.25%
2,710
-440
-14% -$153K
INTC icon
41
Intel
INTC
$466B
$864K 0.24%
27,895
-2,275
-8% -$74.5K
LLY icon
42
Eli Lilly
LLY
$1.07T
$860K 0.24%
950
-150
-14% -$120K
SHEL icon
43
Shell
SHEL
$245B
$776K 0.22%
10,750
– –
ASML icon
44
ASML
ASML
$675B
$774K 0.21%
750
-25
-3% -$24K
V icon
45
Visa
V
$677B
$757K 0.21%
2,885
-100
-3% -$27.4K
NVO
46
Novo Nordisk
NVO
$216B
$714K 0.2%
5,000
-100
-2% -$13.3K
DE icon
47
Deere & Co
DE
$170B
$645K 0.18%
1,726
– –
CVS icon
48
CVS Health
CVS
$137B
$569K 0.16%
9,635
-9,075
-49% -$568K
UNP icon
49
Union Pacific
UNP
$183B
$554K 0.15%
2,450
-210
-8% -$49.2K
CL icon
50
Colgate-Palmolive
CL
$72.6B
$474K 0.13%
4,885
-945
-16% -$87.2K
1
2
3

Similar funds

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $344M AUM 44.86% 1-Year Est. Return
CWM
Cedar Wealth Management Walnut Creek, California $344M AUM 18.78% 1-Year Est. Return
BA
Ballast Advisors Woodbury, Minnesota $344M AUM 16.81% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $344M AUM 23.98% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $343M AUM 17.29% 1-Year Est. Return

Michael J. Puzo's Q2 2024 Portfolio in Review

As of Q2 2024, Michael J. Puzo held 75 positions worth $360M, down 0.13% from $361M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 2.7%. Michael J. Puzo opened no new positions and exited 2, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Michael J. Puzo added most to Vertex Pharmaceuticals in Q2 2024, an estimated $2.15M increase.
  • Michael J. Puzo's biggest Q2 2024 reduction was Nike, cutting an estimated $3.9M.
  • Michael J. Puzo fully exited Edwards Lifesciences in Q2 2024, selling an estimated $320K.
  • Michael J. Puzo's ten largest holdings make up 41% of its $360M portfolio in Q2 2024.
  • Michael J. Puzo opened 0 new positions and closed 2 in Q2 2024.
  • Michael J. Puzo's portfolio value fell 0.13% quarter-over-quarter to $360M.

Based on Michael J. Puzo's 13F filing for Q2 2024, filed 12 Aug 2024.